Advanced Training in Urologic Oncology

泌尿肿瘤学高级培训

基本信息

项目摘要

DESCRIPTION (provided by applicant): Urologic cancers impose a significant burden on the health of Americans. In 2012, an estimated 58,000 individuals will die from cancers that fall under an urologist's care, a figure that accounts for close to 10% of all cancer mortality. Given the general propensity for urologic cancers to affect older people, these numbers are only expected to rise over the next several decades as the overall population of the United States ages. At the same time, the pace of innovation and discovery in translational science and health services research in the area of cancer continues to accelerate. These combined factors require a well prepared research oriented work force that is capable of asking and answering clinically relevant scientific questions that have potential to be translated into impactful discoveries. Notably, a number of sources suggest that today, only a small fraction of urologic surgeons possess such skills. The primary goal of this T32 application is to prepare urology trainees for an academic career in urologic oncology by providing a comprehensive training program comprised of mentored training options in either translational laboratory science or health services research, based upon trainee interest. Investigative themes of the program will be based on the research focus and expertise of a group of 21 multi-disciplinary externally funded faculty members in the University of Michigan Comprehensive Cancer Center composed of individuals from the Departments of Urology, Internal Medicine, Radiation Oncology, Pathology, Surgery, Human Genetics, and Pharmacology- all in the University of Michigan Medical School as well as faculty from the University of Michigan School of Public Health and the University of Michigan School of Dentistry. This proposal is a new application to train 1-2 fellows per year, on an alternate basis, for 2 years. The major objective of the Urologic Oncology Training Program (UOTP) is to prepare individuals for research and teaching careers in the field of academic Urologic Oncology. Graduating urology residents having an M.D. or M.D./PhD. degree will be eligible. The UOTP is structured around a research project supervised by the mentor and a required core curriculum comprised of specific graduate level courses that may lead to a Masters degree. Following acceptance, each trainee will choose between 1 of 2 tracks: translational laboratory science or health services research. The goals of the program are to ensure that each trainee: 1) design, implement, analyze and report a research project, 2) obtain formal instruction on fundamental research methods and 3) gain instruction on either fundamental principles of cancer biology (translational science track) or essential elements of conducting health services research (health services track). There will be a special emphasis on formulating and testing hypotheses that address clinically important questions. Additional training in the effective communication of scientific results as well as grant preparation will be provided to all trainees. The ultimate goal of the UOTP is to prepare trainees for independent careers in academic urologic oncology.
描述(由申请人提供):泌尿系统癌症对美国人的健康造成重大负担。2012年,估计有58,000人将死于泌尿科医生治疗的癌症,这一数字占所有癌症死亡率的近10%。考虑到泌尿系统癌症影响老年人的一般倾向,随着美国总人口的老龄化,这些数字预计在未来几十年内只会上升。与此同时,癌症领域的转化科学和卫生服务研究的创新和发现步伐继续加快。这些综合因素需要一支准备充分的研究型工作队伍,能够提出和回答临床相关的科学问题,这些问题有可能转化为有影响力的发现。值得注意的是,许多资料表明,今天,只有一小部分泌尿外科医生拥有这样的技能。该T32应用程序的主要目标是通过提供全面的培训计划,根据学员的兴趣,在转化实验室科学或卫生服务研究中提供指导培训选项,为泌尿外科肿瘤学的学术生涯做好准备。该计划的调查主题将基于密歇根大学综合癌症中心的21名多学科外部资助教师的研究重点和专业知识,这些教师由泌尿科,内科,放射肿瘤学,病理学,外科,人类遗传学,和药理学-所有这些都在密歇根大学医学院以及密歇根大学公共卫生学院和密歇根大学牙科学院的教师。这项建议是一项新的申请,即每年轮流培训1-2名研究员,为期2年。泌尿肿瘤学培训计划(UOTP)的主要目标是为学术泌尿肿瘤学领域的研究和教学职业做好准备。泌尿科毕业的住院医生有医学博士学位。或医学博士/ PhD.度将符合条件。UOTP是围绕由导师监督的研究项目和所需的核心课程组成的特定研究生水平的课程,可能导致硕士学位。接受后,每个学员将选择2个轨道之一:转化实验室科学或卫生服务研究。该计划的目标是确保每个学员:1)设计,实施,分析和报告研究项目,2)获得基本研究方法的正式指导,3)获得癌症生物学(转化科学轨道)的基本原则或进行卫生服务研究(卫生服务轨道)的基本要素的指导。将有一个特别强调制定和测试的假设,解决临床上重要的问题。将向所有受训人员提供关于有效传播科学成果以及准备赠款的额外培训。UOTP的最终目标是为学员在学术泌尿肿瘤学的独立职业做好准备。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRENT K. HOLLENBECK其他文献

BRENT K. HOLLENBECK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRENT K. HOLLENBECK', 18)}}的其他基金

Physician dispensing of oral specialty drugs for advanced prostate cancer and its implications for patients
医生对晚期前列腺癌口服专科药物的配药及其对患者的影响
  • 批准号:
    10862259
  • 财政年份:
    2023
  • 资助金额:
    $ 14.75万
  • 项目类别:
Physician dispensing of oral specialty drugs for advanced prostate cancer and its implications for patients
医生对晚期前列腺癌口服专科药物的配药及其对患者的影响
  • 批准号:
    10560826
  • 财政年份:
    2023
  • 资助金额:
    $ 14.75万
  • 项目类别:
Aligning financial incentives to promote rational use of active surveillance for prostate cancer
调整财政激励措施以促进前列腺癌主动监测的合理使用
  • 批准号:
    10416477
  • 财政年份:
    2022
  • 资助金额:
    $ 14.75万
  • 项目类别:
Aligning financial incentives to promote rational use of active surveillance for prostate cancer
调整财政激励措施以促进前列腺癌主动监测的合理使用
  • 批准号:
    10592422
  • 财政年份:
    2022
  • 资助金额:
    $ 14.75万
  • 项目类别:
Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
医疗保险责任医疗组织加速转向下行风险:对老年患者临床质量和成本的影响
  • 批准号:
    10432116
  • 财政年份:
    2020
  • 资助金额:
    $ 14.75万
  • 项目类别:
Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
医疗保险责任医疗组织加速转向下行风险:对老年患者临床质量和成本的影响
  • 批准号:
    10625489
  • 财政年份:
    2020
  • 资助金额:
    $ 14.75万
  • 项目类别:
Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
医疗保险责任医疗组织加速转向下行风险:对老年患者临床质量和成本的影响
  • 批准号:
    10862329
  • 财政年份:
    2020
  • 资助金额:
    $ 14.75万
  • 项目类别:
Impact of urologist practice organization and health policy on prostate cancer treatment, overtreatment and spending
泌尿科医生执业组织和卫生政策对前列腺癌治疗、过度治疗和支出的影响
  • 批准号:
    10224611
  • 财政年份:
    2017
  • 资助金额:
    $ 14.75万
  • 项目类别:
Impact of urologist practice organization and health policy on prostate cancer treatment, overtreatment and spending
泌尿科医生执业组织和卫生政策对前列腺癌治疗、过度治疗和支出的影响
  • 批准号:
    9750134
  • 财政年份:
    2017
  • 资助金额:
    $ 14.75万
  • 项目类别:
Accountable care organizations and the diffusion of new surgical procedures
负责任的护理组织和新外科手术的传播
  • 批准号:
    9067196
  • 财政年份:
    2015
  • 资助金额:
    $ 14.75万
  • 项目类别:

相似海外基金

Urologic Oncology Research Training Grant
泌尿肿瘤学研究培训补助金
  • 批准号:
    9749998
  • 财政年份:
    2019
  • 资助金额:
    $ 14.75万
  • 项目类别:
Advanced Training in Urologic Oncology
泌尿肿瘤学高级培训
  • 批准号:
    10646219
  • 财政年份:
    2014
  • 资助金额:
    $ 14.75万
  • 项目类别:
Advanced Training in Urologic Oncology
泌尿肿瘤学高级培训
  • 批准号:
    10427182
  • 财政年份:
    2014
  • 资助金额:
    $ 14.75万
  • 项目类别:
Advanced Training in Urologic Oncology
泌尿肿瘤学高级培训
  • 批准号:
    9793339
  • 财政年份:
    2014
  • 资助金额:
    $ 14.75万
  • 项目类别:
Advanced Training in Urologic Oncology
泌尿肿瘤学高级培训
  • 批准号:
    9281689
  • 财政年份:
    2014
  • 资助金额:
    $ 14.75万
  • 项目类别:
Urologic Oncology Research Training Grant
泌尿肿瘤学研究培训补助金
  • 批准号:
    7235998
  • 财政年份:
    1999
  • 资助金额:
    $ 14.75万
  • 项目类别:
Urologic Oncology Research Training Grant
泌尿肿瘤学研究培训补助金
  • 批准号:
    8299404
  • 财政年份:
    1999
  • 资助金额:
    $ 14.75万
  • 项目类别:
T32 Urologic Oncology Research Training Program
T32 泌尿肿瘤学研究培训计划
  • 批准号:
    10024657
  • 财政年份:
    1999
  • 资助金额:
    $ 14.75万
  • 项目类别:
T32 Urologic Oncology Research Training Program
T32 泌尿肿瘤学研究培训计划
  • 批准号:
    10474284
  • 财政年份:
    1999
  • 资助金额:
    $ 14.75万
  • 项目类别:
Urologic Oncology Research Training Grant
泌尿肿瘤学研究培训补助金
  • 批准号:
    6845175
  • 财政年份:
    1999
  • 资助金额:
    $ 14.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了